GL1X · GenesisL1 explorer

Ligand · MR5

MR5 · 4-(1,3-benzoxazol-2-yl)-2,6-dibromophenol

MR5, 4-(1,3-benzoxazol-2-yl)-2,6-dibromophenol (C13 H7 Br2 N O2, 369.0 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues within 4.5 Å, the residues it binds most and the…

Component
MR5
Formula
C13 H7 Br2 N O2
Class
ligand
Structures
2
PDB entries
1

Binding sites

MR5 in 2 structures; the first of them:

  • 2QGD · Human transthyretin (TTR) complexed with 2-(3,5-Dibromo-4-hydroxyphenyl)benzoxazole · MR5 A200 · binds LYS15, LEU17, THR106, ALA108, LEU110, SER117, THR118, THR119
  • 2QGD · Human transthyretin (ttr) complexed with 2-(3,5-dibromo-4- HYDROXYPHENYL)BENZOXAZOLE · MR5 A200 · binds LYS15, LEU17, THR106, ALA108, LEU110, SER117, THR118, THR119

Residues it binds most

LEU 4, THR 4, ALA 4, LYS 4, SER 4, VAL 2 (residue and the binding sites it lines).

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.